ID93+GLA-SE

BIOLOGICAL2 trials

Sponsors

Quratis Inc.

Conditions

Tuberculosis

Phase 1

Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent

Quratis Inc.Tuberculosis

Start: 2019-04-02End: 2020-12-31Updated: 2019-07-23

Phase 2

Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers

Quratis Inc.Tuberculosis

Start: 2018-05-31End: 2020-06-30Updated: 2019-05-31

Related Papers

Safety and implementation of phase I randomized GLA-SE–adjuvanted CH505TF gp120 HIV vaccine trial in newborns

Journal of Clinical Investigation2025-04-031 citations

Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

2023-05-1119 citations